BACKGROUND: Up to 30% of women with vaginal symptoms are not assigned a diagnosis after standard diagnostic assessment. METHODS: We compared premenopausal women with idiopathic vaginitis (IV) or vulvodynia (VVD) to healthy controls. Microbiota were characterized using rRNA sequencing. Cytokines/chemokines (IL-10, IL-1α, IL-1β, IL-6, IL-8, IL-2, IL-18, IL-4, IL-9, and IL-13) were measured in vaginal lavage fluid using the Meso Scale Discovery platform or ELISA (IL-1ra). Immunoglobulins were measured in vaginal lavage fluid using a bead-based immunoassay (Millipore). Cases and controls were compared using Kruskal-Wallis, analysis of variance, and linear regression or (for microbiome composition) the Bray-Curtis dissimilarity statistic. RESULTS: We compared 20 women with IV, 30 with VVD, and 52 controls. Most (80%) had greater than 90% 16S rRNA gene sequences from Lactobacillus crispatus, L. jensenii, L. gasseri, or L. iners. In analyses adjusted for age and hormonal contraception (HC), Gardnerella vaginalis was less prevalent and abundant in women with VVD (2/30, 7%) versus controls (16/52, 31%) or IV (5/20, 25%) (P = 0.030). Bray-Curtis dissimilarity was not significantly different between IV and controls or VVD. Fungal sequences were only detected in 5 participants: 2 control, 1 IV, 2 VVD. In univariate analysis, cytokines were not associated with diagnosis. Median vaginal concentration of IgE (but not other immunoglobulins) was lower in women with VVD (P = 0.006). CONCLUSIONS: Minimal differences in vaginal microbiota and inflammatory markers between women with IV, VVD or controls suggest no striking association between vaginal bacteria, fungi or inflammation and diagnosis in these women.
BACKGROUND: Up to 30% of women with vaginal symptoms are not assigned a diagnosis after standard diagnostic assessment. METHODS: We compared premenopausal women with idiopathic vaginitis (IV) or vulvodynia (VVD) to healthy controls. Microbiota were characterized using rRNA sequencing. Cytokines/chemokines (IL-10, IL-1α, IL-1β, IL-6, IL-8, IL-2, IL-18, IL-4, IL-9, and IL-13) were measured in vaginal lavage fluid using the Meso Scale Discovery platform or ELISA (IL-1ra). Immunoglobulins were measured in vaginal lavage fluid using a bead-based immunoassay (Millipore). Cases and controls were compared using Kruskal-Wallis, analysis of variance, and linear regression or (for microbiome composition) the Bray-Curtis dissimilarity statistic. RESULTS: We compared 20 women with IV, 30 with VVD, and 52 controls. Most (80%) had greater than 90% 16S rRNA gene sequences from Lactobacillus crispatus, L. jensenii, L. gasseri, or L. iners. In analyses adjusted for age and hormonal contraception (HC), Gardnerella vaginalis was less prevalent and abundant in women with VVD (2/30, 7%) versus controls (16/52, 31%) or IV (5/20, 25%) (P = 0.030). Bray-Curtis dissimilarity was not significantly different between IV and controls or VVD. Fungal sequences were only detected in 5 participants: 2 control, 1 IV, 2 VVD. In univariate analysis, cytokines were not associated with diagnosis. Median vaginal concentration of IgE (but not other immunoglobulins) was lower in women with VVD (P = 0.006). CONCLUSIONS: Minimal differences in vaginal microbiota and inflammatory markers between women with IV, VVD or controls suggest no striking association between vaginal bacteria, fungi or inflammation and diagnosis in these women.
Authors: David C Foster; Katherine H Piekarz; Thomas I Murant; Randi LaPoint; Constantine G Haidaris; Richard P Phipps Journal: Am J Obstet Gynecol Date: 2007-04 Impact factor: 8.661
Authors: Jane R Schwebke; Stephanie N Taylor; Ronald Ackerman; Robert Schlaberg; Neil B Quigley; Charlotte A Gaydos; Steven E Chavoustie; Paul Nyirjesy; Carmelle V Remillard; Philip Estes; Byron McKinney; Damon K Getman; Craig Clark Journal: J Clin Microbiol Date: 2020-01-28 Impact factor: 5.948
Authors: Seth M Bloom; Nomfuneko A Mafunda; Benjamin M Woolston; Matthew R Hayward; Josephine F Frempong; Aaron B Abai; Jiawu Xu; Alissa J Mitchell; Xavier Westergaard; Fatima A Hussain; Nondumiso Xulu; Mary Dong; Krista L Dong; Thandeka Gumbi; F Xolisile Ceasar; Justin K Rice; Namit Choksi; Nasreen Ismail; Thumbi Ndung'u; Musie S Ghebremichael; David A Relman; Emily P Balskus; Caroline M Mitchell; Douglas S Kwon Journal: Nat Microbiol Date: 2022-03-03 Impact factor: 30.964
Authors: Caroline M Mitchell; Nanxun Ma; Alissa J Mitchell; Michael C Wu; D J Valint; Sean Proll; Susan D Reed; Katherine A Guthrie; Andrea Z Lacroix; Joseph C Larson; Robert Pepin; Daniel Raftery; David N Fredricks; Sujatha Srinivasan Journal: Am J Obstet Gynecol Date: 2021-03-04 Impact factor: 10.693
Authors: Mykhaylo Usyk; Nicolas F Schlecht; Sarah Pickering; LaShanda Williams; Christopher C Sollecito; Ana Gradissimo; Carolina Porras; Mahboobeh Safaeian; Ligia Pinto; Rolando Herrero; Howard D Strickler; Shankar Viswanathan; Anne Nucci-Sack; Angela Diaz; Robert D Burk Journal: Nat Commun Date: 2022-01-11 Impact factor: 14.919
Authors: Caroline M Mitchell; Sujatha Srinivasan; Nanxun Ma; Susan D Reed; Michael C Wu; Noah G Hoffman; Daniel J Valint; Sean Proll; Tina L Fiedler; Kathy J Agnew; Katherine A Guthrie; David N Fredricks Journal: J Infect Dis Date: 2021-06-15 Impact factor: 5.226